Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Weiner, Gilbert R.
EIR
•Weiner, Gilbert R.•April 30, 2015

Weiner, Gilbert R. – FDA EIR, Apr 30, 2015

Record Details

An FDA inspection was conducted at the clinical investigator site of Dr. Gilbert R. Weiner and the associated Contract Research Organization (b)(4) from April 20 to April 30, 2015. This high-priority inspection was a pre-approval and follow-up review focused on compliance with Good Clinical Practice for investigational pharmaceutical trials, particularly Protocol CV181169.The inspection identified two main objectionable conditions. Firstly, there was a failure to prepare and maintain adequate case histories. This included a lack of documentation for when concomitant medication information was obtained and entered for all randomized subjects, and insufficient records at screening to confirm medication reviews as required by the protocol. Additionally, source documentation for (b)(4) analysis lacked kit lot numbers, expiration dates, and contemporaneous recording of results for all randomized subjects.Secondly, the investigation was not conducted in accordance with the signed statement of investigator and the investigational plan. A specific instance cited was a subject undergoing more (b)(4) procedures than permitted by the IRB-approved protocol. These issues represent deviations from regulatory requirements under 21 CFR 312.62(b) and 312.60.At the inspection's conclusion, a Form FDA 483 was issued, detailing these observations. Management acknowledged the findings and committed to providing a written response within 15 business days. The FDA strongly encouraged voluntary corrective actions to address the serious conditions and avoid potential legal sanctions.

Company
Weiner, Gilbert R.
Inspection date
April 30, 2015
Product type
drugs
Office
Florida District Office
People
  • Gilbert R. Weiner (recipient)
  • Samantha Amaba (company_representative)
  • Craig A. Garmendia (investigator)
  • Jenny M. Guerra (company_representative)
  • Ivette Lopez (company_representative)
View Company Profile

ID · 855ca011-ca52-4177-9317-e0e8923aa3a4

Violation Codes3
21 CFR 312.6021 CFR 312.62(b)21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Weiner, Gilbert R.
  • 483 - 2013-11-25November 25, 2013
  • WARNING_LETTER - 2013-11-25November 25, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Weiner, Gilbert R.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.